Completed OBSERVATIONAL NCT02067806

Observational Study on 2-chloroprocaine Hydrochloride 1% (PASS)

Observational Prospective Study on 2-chloroprocaine Hydrochloride 1% Safety in Intrathecal Anesthesia

Sponsor: Sintesi Research Srl

Conditions Neurological Complication, in Particular TNS or CES

Interventions 2-chloroprocaine hydrochloride, 1%

Updated 10 times since 2017 Last updated: Jun 8, 2021 Started: Nov 30, 2013 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02067806, this observational or N/A phase trial focuses on Neurological Complication, in Particular TNS or CES and remains completed. Sponsored by Sintesi Research Srl, it has been updated 10 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Sep 2021 — Dec 2022 [monthly]

Completed

▶ Show 5 earlier versions

Jan 2021 — Sep 2021 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sintesi Research Srl
Sintetica SA

Data source: Sintetica SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Malle, Belgium